{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:19:07Z","timestamp":1776745147635,"version":"3.51.2"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12264-020-00582-8","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:05:50Z","timestamp":1602043550000},"page":"1299-1314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington\u2019s and Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Talita","family":"Glaser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Andrejew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gatha","family":"Oliveira-Giacomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deidiane Elisa","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Bonfim Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6800-0942","authenticated-orcid":false,"given":"Alexey","family":"Semyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-9389","authenticated-orcid":false,"given":"Peter","family":"Illes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-066X","authenticated-orcid":false,"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-3815","authenticated-orcid":false,"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","unstructured":"MacDonald Gillian P.Buckler, Alan J.Altherr, MichaelTagle, DaniloSnell, Russell et al. MEB. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 1993, 72:971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"582_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5214\/ans.0972.7531.210308","volume":"21","author":"AA Rikani","year":"2014","unstructured":"Rikani AA, Choudhry Z, Choudhry AM, Rizvi N, Ikram H, Mobassarah NJ, et al. The mechanism of degeneration of striatal neuronal subtypes in Huntington disease. Ann Neurosci 2014, 21:112\u2013114.","journal-title":"Ann Neurosci"},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s12264-019-00421-5","volume":"35","author":"W Yang","year":"2019","unstructured":"Yang W, Xie J, Qiang Q, Li L, Lin X, Ren Y, et al. Gedunin degrades aggregates of mutant huntingtin protein and intranuclear inclusions via the proteasomal pathway in neurons and fibroblasts from patients with Huntington\u2019s disease. Neurosci Bull 2019, 35:1024\u20131034.","journal-title":"Neurosci Bull"},{"key":"582_CR4","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T, Lila R. Parkinson \u2019 s disease. Lancet 2009, 373:2055\u20132066.","journal-title":"Lancet"},{"key":"582_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 2009, 24:114\u2013125.","journal-title":"Front Neurol Neurosci"},{"key":"582_CR6","doi-asserted-by":"crossref","first-page":"117906951876136","DOI":"10.1177\/1179069518761360","volume":"12","author":"DE Mor","year":"2018","unstructured":"Mor DE, Ischiropoulos H. The convergence of dopamine and alpha-synuclein: implications for Parkinson\u2019s disease. J Exp Neurosci 2018, 12:1179069518761360.","journal-title":"J Exp Neurosci"},{"key":"582_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s40572-017-0143-2","volume":"4","author":"SM Fleming","year":"2017","unstructured":"Fleming SM. Mechanisms of gene-environment interactions in Parkinson\u2019s disease. Curr Env Heal Rep 2017, 4:192\u2013199.","journal-title":"Curr Env Heal Rep"},{"key":"582_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0031-1299782","volume":"31","author":"KR Kumar","year":"2011","unstructured":"Kumar KR, Djarmati-Westenberger A, Grunewald A. Genetics of Parkinson\u2019s disease. Semin Neurol 2011, 31:433\u2013440.","journal-title":"Semin Neurol"},{"key":"582_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","volume":"9","author":"J Trinh","year":"2013","unstructured":"Trinh J, Farrer M. Advances in the genetics of Parkinson disease. Nat Rev Neurol 2013, 9:445\u2013454.","journal-title":"Nat Rev Neurol"},{"key":"582_CR10","doi-asserted-by":"crossref","unstructured":"Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F. Managing juvenile Huntington\u2019s disease. Neurodegener Dis Manag 2014, 3.","DOI":"10.2217\/nmt.13.18"},{"key":"582_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.64.1.20","volume":"64","author":"MR DeLong","year":"2007","unstructured":"DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007, 64:20\u201324.","journal-title":"Arch Neurol"},{"key":"582_CR12","first-page":"1184","volume":"40","author":"MR DeLong","year":"2000","unstructured":"DeLong MR. [Functional and pathophysiological models of the basal ganglia: therapeutic implications]. Rinsho Shinkeigaku 2000, 40:1184.","journal-title":"Rinsho Shinkeigaku"},{"key":"582_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng571","volume":"28","author":"AR Curtis","year":"2001","unstructured":"Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001, 28:350\u2013354.","journal-title":"Nat Genet"},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2008.11.001","volume":"18","author":"A Nambu","year":"2008","unstructured":"Nambu A. Seven problems on the basal ganglia. Curr Opin Neurobiol 2008, 18:595\u2013604.","journal-title":"Curr Opin Neurobiol"},{"key":"582_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)80510-3","volume":"21","author":"MJ Berridge","year":"1998","unstructured":"Berridge MJ. Neuronal calcium signaling. Neuron 1998, 21:13\u201326.","journal-title":"Neuron"},{"key":"582_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-319-26974-0_7","volume":"898","author":"T Capiod","year":"2016","unstructured":"Capiod T. Extracellular calcium has multiple targets to control cell proliferation. Adv Exp Med Biol 2016, 898:133\u2013156.","journal-title":"Adv Exp Med Biol"},{"key":"582_CR17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","volume":"131","author":"DE Clapham","year":"2007","unstructured":"Clapham DE. Calcium signaling. Cell, 2007, 131:1047\u20131058.","journal-title":"Cell"},{"key":"582_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ceca.2016.04.005","volume":"60","author":"RM La Rovere","year":"2016","unstructured":"La Rovere RM, Roest G, Bultynck G, Parys JB. Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy. Cell Calcium 2016, 60:74\u201387.","journal-title":"Cell Calcium"},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceca.2016.02.011","volume":"59","author":"AB Toth","year":"2016","unstructured":"Toth AB, Shum AK, Prakriya M. Regulation of neurogenesis by calcium signaling. Cell Calcium 2016, 59:124\u2013134.","journal-title":"Cell Calcium"},{"key":"582_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/19336950.2015.1071747","volume":"9","author":"R Kraft","year":"2015","unstructured":"Kraft R. STIM and ORAI proteins in the nervous system. Channels (Austin) 2015, 9:245\u2013252.","journal-title":"Channels (Austin)"},{"key":"582_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1152\/physrev.00057.2003","volume":"85","author":"AB Parekh","year":"2005","unstructured":"Parekh AB, Putney Jr. JW. Store-operated calcium channels. Physiol Rev 2005, 85:757\u2013810.","journal-title":"Physiol Rev"},{"key":"582_CR22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrm3414","volume":"13","author":"J Soboloff","year":"2012","unstructured":"Soboloff J, Rothberg BS, Madesh M, Gill DL. STIM proteins: dynamic calcium signal transducers. Nat Rev Mol Cell Biol 2012, 13:549\u2013565.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ncb1590","volume":"9","author":"JP Yuan","year":"2007","unstructured":"Yuan JP, Zeng W, Huang GN, Worley PF, Muallem S. STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol 2007, 9:636\u2013645.","journal-title":"Nat Cell Biol"},{"key":"582_CR24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3570673","volume":"357","author":"RT Williams","year":"2001","unstructured":"Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, Eid JP, et al. Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J 2001, 357:673\u2013685.","journal-title":"Biochem J"},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2007.11.039","volume":"131","author":"O Brandman","year":"2007","unstructured":"Brandman O, Liou J, Park WS, Meyer T. STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 2007, 131:1327\u20131339.","journal-title":"Cell"},{"key":"582_CR26","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","volume":"71","author":"M Brini","year":"2014","unstructured":"Brini M, Cal\u00ec T, Ottolini D, Carafoli E. Neuronal calcium signaling: Function and dysfunction. Cell Mol Life Sci 2014, 71:2787\u20132814.","journal-title":"Cell Mol Life Sci"},{"key":"582_CR27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","volume":"483","author":"E Popugaeva","year":"2017","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny I. Dysregulation of neuronal calcium homeostasis in Alzheimer\u2019s disease - A therapeutic opportunity? Biochem Biophys Res Commun 2017, 483:998\u20131004.","journal-title":"Biochem Biophys Res Commun"},{"key":"582_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","volume":"70","author":"E Pchitskaya","year":"2018","unstructured":"Pchitskaya E, Popugaeva E, Bezprozvanny I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 2018, 70: 87\u201394.","journal-title":"Cell Calcium"},{"key":"582_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcdb.2018.12.002","volume":"95","author":"T Glaser","year":"2019","unstructured":"Glaser T, Arnaud Sampaio VF, Lameu C, Ulrich H. Calcium signalling: A common target in neurological disorders and neurogenesis. Semin Cell Dev Biol 2019, 95: 25\u201333.","journal-title":"Semin Cell Dev Biol"},{"key":"582_CR30","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","volume":"72","author":"N Chen","year":"1999","unstructured":"Chen N, Luo T, Wellington C, Metzler M, McCutcheon K, Hayden MR, et al. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem 1999, 72:1890\u20131898.","journal-title":"J Neurochem"},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MM Fan","year":"2007","unstructured":"Fan MM, Raymond LA. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease. Prog Neurobiol 2007, 81: 272\u2013293.","journal-title":"Prog Neurobiol"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, et al. Increased sensitivity to N-methyl-D-aspartate in a mouse model of Huntington\u2019s disease Neuron 2002, 33:849\u2013860.","journal-title":"Neuron"},{"key":"582_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuron.2010.01.010","volume":"65","author":"MS Levine","year":"2010","unstructured":"Levine MS, Cepeda C, Andr\u00e9 VM. Location, location, location: Contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington\u2019s disease. Neuron 2010, 65:145\u2013147.","journal-title":"Neuron"},{"key":"582_CR34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron 2010, 65:178\u2013190.","journal-title":"Neuron"},{"key":"582_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin JL, Surmeier DJ. Corticostriatal synaptic adaptations in Huntington\u2019s disease. Curr Opin Neurobiol 2015, 33:53\u201362.","journal-title":"Curr Opin Neurobiol"},{"key":"582_CR36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","volume":"483","author":"LA Raymond","year":"2017","unstructured":"Raymond LA. Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochem Biophys Res Commun 2017, 483:1051\u20131062.","journal-title":"Biochem Biophys Res Commun"},{"key":"582_CR37","first-page":"1807","volume":"81","author":"G Barbin","year":"2001","unstructured":"Barbin G, Pollard H, Gaiarsa JL, Ben-Ari Y, Barria A, Muller D, et al. Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. J Neurosci 2001, 81:1807\u20131817.","journal-title":"J Neurosci"},{"key":"582_CR38","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 2007, 3:e82.","journal-title":"PLoS Genet"},{"key":"582_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","volume":"39","author":"TS Tang","year":"2003","unstructured":"Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 2003, 39:227\u2013239.","journal-title":"Neuron"},{"key":"582_CR40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.4411-08.2009","volume":"29","author":"TS Tang","year":"2009","unstructured":"Tang TS, Guo C, Wang H, Chen X, Bezprozvanny I. Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington\u2019s disease mouse model. J Neurosci 2009, 29:1257\u20131266.","journal-title":"J Neurosci"},{"key":"582_CR41","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"TS Tang","year":"2005","unstructured":"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, et al. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease. Proc Natl Acad Sci U S A 2005, 102:2602\u20132607.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"582_CR42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschl\u00e4ger","year":"2018","unstructured":"Lautenschl\u00e4ger J, Stephens AD, Fusco G, Str\u00f6hl F, Curry N, Zacharopoulou M, et al. C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat Commun 2018, 9: 712-25.","journal-title":"Nat Commun"},{"key":"582_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-017-0177-3","volume":"34","author":"X Chen","year":"2018","unstructured":"Chen X, Xue B, Wang J, Liu H, Shi L, Xie J. Potassium channels: A potential therapeutic target for Parkinson\u2019s disease. Neurosci Bull 2018, 34:341\u2013348.","journal-title":"Neurosci Bull"},{"key":"582_CR44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbrc.2016.08.153","volume":"483","author":"D Cieri","year":"2016","unstructured":"Cieri D, Brini M, Cali T. Emerging (and converging) pathways in Parkinson\u2019s disease: keeping mitochondrial wellness. Biochem Biophys Res Commun 2016, 483:1020\u20131030.","journal-title":"Biochem Biophys Res Commun"},{"key":"582_CR45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","volume":"357","author":"T Cali","year":"2014","unstructured":"Cali T, Ottolini D, Brini M. Calcium signaling in Parkinson\u2019s disease. Cell Tissue Res 2014, 357:439\u2013454.","journal-title":"Cell Tissue Res"},{"key":"582_CR46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","volume":"10","author":"SV Zaichick","year":"2017","unstructured":"Zaichick S V, McGrath KM, Caraveo G. The role of Ca2+ signaling in Parkinson\u2019s disease. Dis Model Mech 2017, 10:519\u2013535.","journal-title":"Dis Model Mech"},{"key":"582_CR47","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 2007, 447:1081\u20131086.","journal-title":"Nature"},{"key":"582_CR48","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","volume":"29","author":"JN Guzman","year":"2009","unstructured":"Guzman JN, Sanchez-Padilla J, Chan CS, Surmeier DJ. Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci 2009, 29:11011\u201311019.","journal-title":"J Neurosci"},{"key":"582_CR49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1523\/JNEUROSCI.4341-06.2007","volume":"27","author":"M Puopolo","year":"2007","unstructured":"Puopolo M, Raviola E, Bean BP. Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci 2007, 27:645\u2013656.","journal-title":"J Neurosci"},{"key":"582_CR50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","volume":"70","author":"E Pchitskaya","year":"2017","unstructured":"Pchitskaya E, Popugaeva E, Bezprozvanny I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 2017, 70:87\u201394.","journal-title":"Cell Calcium"},{"key":"582_CR51","doi-asserted-by":"crossref","first-page":"a009290","DOI":"10.1101\/cshperspect.a009290","volume":"2","author":"DJ Surmeier","year":"2012","unstructured":"Surmeier DJ, Guzman JN, Sanchez J, Schumacker PT. Physiological phenotype and vulnerability in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2012, 2:a009290.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"582_CR52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","volume":"483","author":"DJ Surmeier","year":"2016","unstructured":"Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E. Calcium and Parkinson\u2019s disease. Biochem Biophys Res Commun 2016, 483:1013\u20131019.","journal-title":"Biochem Biophys Res Commun"},{"key":"582_CR53","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1523\/JNEUROSCI.1680-15.2015","volume":"35","author":"T Pathak","year":"2015","unstructured":"Pathak T, Agrawal T, Richhariya S, Sadaf S, Hasan G. Store-operated calcium entry through orai is required for transcriptional maturation of the flight circuit in Drosophila. J Neurosci 2015, 35:13784\u201313799.","journal-title":"J Neurosci"},{"key":"582_CR54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2015.05.031","volume":"104","author":"G Burnstock","year":"2016","unstructured":"Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology 2016, 104:4\u201317.","journal-title":"Neuropharmacology"},{"key":"582_CR55","doi-asserted-by":"publisher","unstructured":"Oliveira-Giacomelli \u00e1gatha, Naaldijk Y, Sard\u00e1-Arroyo L, Gon\u00e7alves MCB, Corr\u00eaa-Velloso J, Pillat MM, et al. Purinergic receptors in neurological diseases with motor symptoms: Targets for therapy. Front Pharmacol 2018, 9: 325.\u00a0https:\/\/doi.org\/10.3389\/fphar.2018.00325.","DOI":"10.3389\/fphar.2018.00325"},{"key":"582_CR56","doi-asserted-by":"crossref","unstructured":"Ribeiro DE, Glaser T, Oliveira-Giacomelli, Ulrich H. Purinergic receptors in neurogenic processes. Brain Res Bull 2019, 151: 3\u201311.","DOI":"10.1016\/j.brainresbull.2018.12.013"},{"key":"582_CR57","doi-asserted-by":"crossref","first-page":"473712","DOI":"10.1155\/2012\/473712","volume":"2012","author":"F Ghiringhelli","year":"2012","unstructured":"Ghiringhelli F, Bruchard M, Chalmin F, Rebe C. Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape. J Biomed Biotechnol 2012, 2012:473712.","journal-title":"J Biomed Biotechnol"},{"key":"582_CR58","first-page":"423","volume":"7","author":"H Zimmermann","year":"2008","unstructured":"Zimmermann H. Ectonucleotidases in the Nervous System. Purinergic Signalling in Neuron-Glia Interactions. Wiley 2008, 7:423\u2013436.","journal-title":"Purinergic Signalling in Neuron-Glia Interactions. Wiley"},{"key":"582_CR59","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2741\/e298","volume":"3","author":"G Burnstock","year":"2011","unstructured":"Burnstock G. Introductory overview of purinergic signalling. Front Biosci (Elite Ed) 2011, 3:896\u2013900.","journal-title":"Front Biosci (Elite Ed)"},{"key":"582_CR60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainresbull.2018.12.008","volume":"151","author":"EM Jimenez-Mateos","year":"2019","unstructured":"Jimenez-Mateos EM, Smith J, Nicke A, Engel T. Regulation of P2X7 receptor expression and function in the brain. Brain Res Bull 2019, 151:153\u2013163.","journal-title":"Brain Res Bull"},{"key":"582_CR61","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0028-3908(97)00141-X","volume":"36","author":"C Virginio","year":"1997","unstructured":"Virginio C, Church D, North RA, Surprenant A. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 1997, 36:1285\u20131294.","journal-title":"Neuropharmacology"},{"key":"582_CR62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2019.03.010","volume":"151","author":"I von K\u00fcgelgen","year":"2019","unstructured":"von K\u00fcgelgen I. Pharmacology of P2Y receptors. Brain Res Bull 2019, 151:12-24.","journal-title":"Brain Res Bull"},{"key":"582_CR63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0165-1838(00)00154-5","volume":"81","author":"JT Neary","year":"2000","unstructured":"Neary JT. Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis. J Auton Nerv Syst 2000, 81:200\u20134.","journal-title":"J Auton Nerv Syst"},{"key":"582_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0717-5","author":"T Glaser","year":"2020","unstructured":"Glaser T, Shimojo H, Ribeiro DE, Martins PPL, Beco RP, Kosinski M, et al. ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington\u2019s disease: a novel approach for cell clock research. Mol Psychiatry, 2020. https:\/\/doi.org\/10.1038\/s41380-020-0717-5.","journal-title":"Mol Psychiatry"},{"key":"582_CR65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-801022-8.00004-0","volume":"119","author":"A Mori","year":"2014","unstructured":"Mori A. Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson\u2019s disease. Int Rev Neurobiol 2014, 119:87\u2013116.","journal-title":"Int Rev Neurobiol"},{"key":"582_CR66","doi-asserted-by":"crossref","unstructured":"Lee YC, Chien CL, Sun CN, Huang CL, Huang NK, Chiang MC, et al. Characterization of the rat A2A adenosine receptor gene: A 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur J Neurosci 2003, 18:1786\u20131796.","DOI":"10.1046\/j.1460-9568.2003.02907.x"},{"key":"582_CR67","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0006-8993(94)91066-9","volume":"649","author":"RA Cunha","year":"1994","unstructured":"Cunha RA, Johansson B, Ploeg I, Sebasti\u00e3o AM, Ribeiro JA, Fredholm BB. Evidence for functionally important adenosine A2A receptors in the rat hippocampus. Brain Res 1994, 649:208\u201316.","journal-title":"Brain Res"},{"key":"582_CR68","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E","volume":"27","author":"P Svenningsson","year":"1997","unstructured":"Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study. Synapse 1997, 27:322\u2013335.","journal-title":"Synapse"},{"key":"582_CR69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(99)00022-1","volume":"261","author":"A Kaelin-Lang","year":"1999","unstructured":"Kaelin-Lang A, Lauterburg T, Burgunder J-M. Expression of adenosine A2A receptors gene in the olfactory bulb and spinal cord of rat and mouse. Neurosci Lett 1999, 261:189\u201391.","journal-title":"Neurosci Lett"},{"key":"582_CR70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jnc.13885","volume":"140","author":"C Cervetto","year":"2017","unstructured":"Cervetto C, Venturini A, Passalacqua M, Guidolin D, Genedani S, Fuxe K, et al. A2A-D2 receptor\u2013receptor interaction modulates gliotransmitter release from striatal astrocyte processes. J Neurochem 2017, 140:268\u2013279.","journal-title":"J Neurochem"},{"key":"582_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00043","volume":"12","author":"DO Borroto-Escuela","year":"2018","unstructured":"Borroto-Escuela DO, Hinz S, Navarro G, Franco R, M\u00fcller CE, Fuxe K. Understanding the role of adenosine A2AR heteroreceptor complexes in neurodegeneration and neuroinflammation. Front Neurosci 2018, 12:1\u201311.","journal-title":"Front Neurosci"},{"key":"582_CR72","doi-asserted-by":"crossref","first-page":"6975841","DOI":"10.1155\/2017\/6975841","volume":"2017","author":"A Vuorimaa","year":"2017","unstructured":"Vuorimaa A, Rissanen E, Airas L. In vivo PET imaging of adenosine 2A receptors in neuroinflammatory and neurodegenerative disease. Contrast Media Mol Imaging 2017, 2017:6975841.","journal-title":"Contrast Media Mol Imaging"},{"key":"582_CR73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1469-7793.2001.0423f.x","volume":"532","author":"T Shindou","year":"2001","unstructured":"Shindou T, Mori A, Kase H, Ichimura M. Adenosine A 2A receptor enhances GABA A-mediated IPSCs in the rat globus pallidus. J Physiol 2001, 532:423\u2013434.","journal-title":"J Physiol"},{"key":"582_CR74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.bjp.0704702","volume":"136","author":"T Shindou","year":"2002","unstructured":"Shindou T, Nonaka H, Richardson PJ, Mori A, Kase H, Ichimura M. Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus. Br J Pharmacol 2002, 136:296\u2013302.","journal-title":"Br J Pharmacol"},{"key":"582_CR75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2003.08.059","volume":"352","author":"T Shindou","year":"2003","unstructured":"Shindou T, Richardson PJ, Mori A, Kase H, Ichimura M. Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A2A receptors in rats. Neurosci Lett 2003, 352:167\u2013170.","journal-title":"Neurosci Lett"},{"key":"582_CR76","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","volume":"88","author":"S Ferre","year":"1991","unstructured":"Ferre S, Von Euler G, Johansson B, Fredholm BB, Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A 1991, 88:7238\u20137241.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"582_CR77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0922-4106(93)90157-5","volume":"244","author":"S Ferr\u00e9","year":"1993","unstructured":"Ferr\u00e9 S, Snaprud P, Fuxe K. Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes. Eur J Pharmacol 1993, 244:311\u2013315.","journal-title":"Eur J Pharmacol"},{"key":"582_CR78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1100\/tsw.2007.211","volume":"7","author":"S Ferr\u00e9","year":"2007","unstructured":"Ferr\u00e9 S, Ciruela F, Quiroz C, Luj\u00e1n R, Popoli P, Cunha RA, et al. Adenosine receptor heteromers and their integrative role in striatal function. ScientificWorldJournal 2007, 7:74\u201385.","journal-title":"ScientificWorldJournal"},{"key":"582_CR79","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1073\/pnas.97.4.1856","volume":"97","author":"P Svenningsson","year":"2000","unstructured":"Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, et al. Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A 2000, 97:1856\u20131860.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"582_CR80","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature00817","volume":"418","author":"M Lindskog","year":"2002","unstructured":"Lindskog M, Svenningsson P, Pozzi L, Kim Y, Flenberg AA, Bibb JA, et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 2002, 418:774\u2013778.","journal-title":"Nature"},{"key":"582_CR81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","volume":"83","author":"SN Schiffmann","year":"2007","unstructured":"Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferr\u00e9 S. Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 2007, 83:277\u2013292.","journal-title":"Prog Neurobiol"},{"key":"582_CR82","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1469-7793.2001.0423f.x","volume":"532","author":"T Shindou","year":"2001","unstructured":"Shindou T, Mori A, Kase H, Ichimura M. Adenosine A2A receptor enhances GABAA-mediated IPSCs in the rat globus pallidus. J Physiol 2001, 532:423\u2013434.","journal-title":"J Physiol"},{"key":"582_CR83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jnc.13652","volume":"19","author":"S Beggiato","year":"2016","unstructured":"Beggiato S, Tomasini MC, Borelli AC, Borroto-Escuela DO, Fuxe K, Antonelli T, et al. Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission. J Neurochem 2016, 19:254\u2013264.","journal-title":"J Neurochem"},{"key":"582_CR84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/1389203715666140901103205","volume":"15","author":"S Beggiato","year":"2014","unstructured":"Beggiato S, Antonelli T, Tomasini M, Borelli A, Agnati L, Tanganelli S, et al. Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal GABA pathway: Possible relevance for Parkinson\u2019s disease and its treatment. Curr Protein Pept Sci 2014, 15:673\u2013680.","journal-title":"Curr Protein Pept Sci"},{"key":"582_CR85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<132::AID-SYN6>3.0.CO;2-E","volume":"22","author":"R Dayne Mayfield","year":"1996","unstructured":"Dayne Mayfield R, Larson G, Orona RA, Zahniser NR. Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a\/D2 receptor interaction in globus pallidus. Synapse 1996, 22:132\u20138.","journal-title":"Synapse"},{"key":"582_CR86","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/j.1471-4159.1993.tb03526.x","volume":"60","author":"RD Mayfield","year":"1993","unstructured":"Mayfield RD, Suzuki F, Zahniser NR. Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem 1993, 60:2334\u20132337.","journal-title":"J Neurochem"},{"key":"582_CR87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10059-013-0192-9","volume":"36","author":"HW Nam","year":"2013","unstructured":"Nam HW, Bruner RC, Choi DS. Adenosine signaling in striatal circuits and alcohol use disorders. Mol Cells 2013, 36:195\u2013202.","journal-title":"Mol Cells"},{"key":"582_CR88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","volume":"92","author":"K Fuxe","year":"2007","unstructured":"Fuxe K, Ferr\u00e9 S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 2007, 92:210\u2013217.","journal-title":"Physiol Behav"},{"key":"582_CR89","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1523\/JNEUROSCI.20-06-02175.2000","volume":"20","author":"K Chergui","year":"2000","unstructured":"Chergui K, Bouron A, Normand E, Mulle C. Functional GluR6 kainate receptors in the striatum: Indirect downregulation of synaptic transmission. J Neurosci 2000, 20:2175\u20132182.","journal-title":"J Neurosci"},{"key":"582_CR90","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1523\/JNEUROSCI.16-02-00605.1996","volume":"76","author":"A Mori","year":"1996","unstructured":"Mori A, Shindou T, Ichimura M, Nonaka H, Kase H. The role of adenosine A2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 1996, 76:605\u2013611.","journal-title":"J Neurosci"},{"key":"582_CR91","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1523\/JNEUROSCI.20-15-05848.2000","volume":"20","author":"S Aoyama","year":"2000","unstructured":"Aoyama S, Kase H, Borrelli E. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an Adenosine A2A receptor antagonist. J Neurosci 2000, 20:5848\u20135852.","journal-title":"J Neurosci"},{"key":"582_CR92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","volume":"401","author":"DL Rosin","year":"1998","unstructured":"Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J. Immunohistochemical localization of adenosine A(2A) receptors in the rat central nervous system. J Comp Neurol 1998, 401:163\u2013186.","journal-title":"J Comp Neurol"},{"issue":"11 Suppl 6","key":"582_CR93","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/01.wnl.0000095205.33940.99","volume":"61","author":"DL Rosin","year":"2003","unstructured":"Rosin DL, Hettinger BD, Lee A, Linden J. Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function. Neurology 2003, 61 (11 Suppl 6):S12-18.\u00a0https:\/\/doi.org\/10.1212\/01.wnl.0000095205.33940.99.","journal-title":"Neurology"},{"key":"582_CR94","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","volume":"99","author":"S Ferr\u00e9","year":"2002","unstructured":"Ferr\u00e9 S, Karcz-Kubicha M, Hope BT, Popoli P, Burgue\u00f1o J, Guti\u00e9rrez MA, et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proc Natl Acad Sci U S A 2002, 99:11940\u201311945.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"582_CR95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1471-4159.2004.02887.x","volume":"92","author":"RJ Rodrigues","year":"2005","unstructured":"Rodrigues RJ, Alfaro TM, Rebola N, Oliveira CR, Cunha RA. Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 2005, 92:433\u2013441.","journal-title":"J Neurochem"},{"key":"582_CR96","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Cabiale Z, Viv\u00f3 M, Del Arco A, O\u2019Connor WT, Harte MK, M\u00fcller CE, et al. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptors. Neurosci Lett 2002, 324:154\u2013158.","DOI":"10.1016\/S0304-3940(02)00179-9"},{"key":"582_CR97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0028-3908(98)00154-3","volume":"38","author":"S Ferr\u00e9","year":"1999","unstructured":"Ferr\u00e9 S, Popoli P, Rimondini R, Reggio R, Kehr J, Fuxe K. Adenosine A(2A) and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology 1999, 38:129\u2013140.","journal-title":"Neuropharmacology"},{"key":"582_CR98","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1523\/JNEUROSCI.3660-05.2005","volume":"25","author":"A Kachroo","year":"2005","unstructured":"Kachroo A, Orlando LR, Grandy DK, Chen JF, Young AB, Schwarzschild MA. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 2005, 25:10414\u201310419.","journal-title":"J Neurosci"},{"key":"582_CR99","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0893-133X(01)00256-1","volume":"25","author":"P Popoli","year":"2001","unstructured":"Popoli P, P\u00e8zzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, et al. The selective mGlu5 receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D2 receptors in the rat striatum: Interactions with adenosine A2a receptors. Neuropsychopharmacology 2001, 25:505\u2013513.","journal-title":"Neuropsychopharmacology"},{"key":"582_CR100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuron.2007.11.023","volume":"57","author":"N Rebola","year":"2008","unstructured":"Rebola N, Lujan R, Cunha RA, Mulle C. Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 2008, 57:121\u2013134.","journal-title":"Neuron"},{"key":"582_CR101","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1179\/1743132814Y.0000000375","volume":"36","author":"C Zhu","year":"2014","unstructured":"Zhu C, Wang G, Li J, Chen L, Wang C, Wang Y, et al. Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg\/day as augmentation for Parkinson\u2019s disease: a meta-analysis. Neurol Res 2014, 36:1028\u20131034.","journal-title":"Neurol Res"},{"key":"582_CR102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(02)01818-6","volume":"446","author":"A Pinna","year":"2002","unstructured":"Pinna A, Corsi C, Carta AR, Valentini V, Pedata F, Morelli M. Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation. Eur J Pharmacol 2002, 446:75\u201382.","journal-title":"Eur J Pharmacol"},{"key":"582_CR103","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","volume":"127","author":"F Calon","year":"2004","unstructured":"Calon F, Dridi M, Hornykiewicz O, B\u00e9dard PJ, Rajput AH, Di Paolo T. Increased adenosine A2A receptors in the brain of Parkinson\u2019s disease patients with dyskinesias. Brain 2004, 127:1075\u20131084.","journal-title":"Brain"},{"key":"582_CR104","doi-asserted-by":"crossref","first-page":"e17338","DOI":"10.1371\/journal.pone.0017338","volume":"6","author":"M Mishina","year":"2011","unstructured":"Mishina M, Ishiwata K, Naganawa M, Kimura Y, Kitamura S, Suzuki M, et al. Adenosine A2A receptors measured with [11C]TMSX pet in the striata of parkinson\u2019s disease patients. PLoS One 2011, 6: e17338.","journal-title":"PLoS One"},{"key":"582_CR105","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/WNL.0b013e31821ccce4","volume":"76","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Bose SK, Ahmed I, Turkheimer FE, Pavese N, Brooks DJ. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology 2011, 76:1811\u20131816.","journal-title":"Neurology"},{"key":"582_CR106","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/syn.20011","volume":"52","author":"M Tomiyama","year":"2004","unstructured":"Tomiyama M, Kimura T, Maeda T, Tanaka H, Kannari K, Baba MA. Upregulation of striatal adenosine A2A receptor mRNA in 6-Hydroxydopamine-lesioned rats intermittently treated with L-DOPA. Synapse 2004, 52:218\u2013222.","journal-title":"Synapse"},{"key":"582_CR107","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4522(00)00250-5","volume":"100","author":"M Ochi","year":"2000","unstructured":"Ochi M, Koga K, Kurokawa M, Kase H, Nakamura J, Kuwana Y. Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study. Neuroscience 2000, 100:53\u201362.","journal-title":"Neuroscience"},{"key":"582_CR108","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn1632","volume":"9","author":"M Day","year":"2006","unstructured":"Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9:251\u2013259.","journal-title":"Nat Neurosci"},{"key":"582_CR109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2018.03.040","volume":"675","author":"N Kumari","year":"2018","unstructured":"Kumari N, Agrawal S, Kumari R, Sharma D, Luthra P. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson\u2019s disease. Neurosci Lett 2018, 675:74\u201382.","journal-title":"Neurosci Lett"},{"key":"582_CR110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/syn.20295","volume":"60","author":"M Morissette","year":"2006","unstructured":"Morissette M, Dridi M, Calon F, Hadjtahar A, Meltzer L, B\u00e9dard PJ, et al. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors. Synapse 2006, 60:239\u2013250.","journal-title":"Synapse"},{"key":"582_CR111","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","volume":"32","author":"MJ Di\u00f3genes","year":"2012","unstructured":"Di\u00f3genes MJ, Dias RB, Rombo DM, Vicente Miranda H, Maiolino F, Guerreiro P, et al. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. J Neurosci 2012, 32:11750\u201311762.","journal-title":"J Neurosci"},{"key":"582_CR112","first-page":"718","volume":"27","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Batalha VL, Miranda HV, Coelho JE, Gomes R, Gon\u00e7alves FQ, et al. Adenosine A2A receptors modulate \u03b1-synuclein aggregation and toxicity. Cereb Cortex 2017, 27:718\u2013730.","journal-title":"Cereb Cortex"},{"key":"582_CR113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2016.05.040","volume":"283","author":"Q Hu","year":"2016","unstructured":"Hu Q, Ren X, Liu Y, Li Z, Zhang L, Chen X, et al. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy. Exp Neurol 2016, 283:213\u2013223.","journal-title":"Exp Neurol"},{"key":"582_CR114","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988, 85:5733\u20135737.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"582_CR115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","volume":"35","author":"CM Dhaenens","year":"2009","unstructured":"Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, et al. A genetic variation in the ADORA2A gene modifies age at onset in Huntington\u2019s disease. Neurobiol Dis 2009, 35:474\u2013476.","journal-title":"Neurobiol Dis"},{"key":"582_CR116","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass M, Dragunow M, Faull RLM. The pattern of neurodegeneration in Huntington\u2019s disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience 2000, 97:505\u2013519.","journal-title":"Neuroscience"},{"key":"582_CR117","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2005.03169.x","volume":"94","author":"A Bauer","year":"2005","unstructured":"Bauer A, Zilles K, Matusch A, Holzmann C, Riess O, Von H\u00f6rsten S. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington\u2019s disease mutation. J Neurochem 2005, 94:639\u2013650.","journal-title":"J Neurochem"},{"key":"582_CR118","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","volume":"354","author":"JHJ Cha","year":"1999","unstructured":"Cha JHJ, Frey AS, Alsdorf SA, Kerner JA, Kosinski CM, Mangiarini L, et al. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philos Trans R Soc B Biol Sci 1999, 354:981\u2013989.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"582_CR119","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","volume":"280","author":"MC Chiang","year":"2005","unstructured":"Chiang MC, Lee YC, Huang CL, Chern Y. cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues. J Biol Chem 2005, 280:14331\u201314340.","journal-title":"J Biol Chem"},{"key":"582_CR120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nbd.2010.09.021","volume":"41","author":"S Mievis","year":"2011","unstructured":"Mievis S, Blum D, Ledent C. A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 2011, 41:570\u2013576.","journal-title":"Neurobiol Dis"},{"key":"582_CR121","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","volume":"15","author":"I Villar-Men\u00e9ndez","year":"2013","unstructured":"Villar-Men\u00e9ndez I, Blanch M, Tyebji S, Pereira-Veiga T, Albasanz JL, Mart\u00edn M, et al. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease. Neuromolecular Med 2013, 15:295\u2013309.","journal-title":"Neuromolecular Med"},{"key":"582_CR122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","volume":"93","author":"SY Chou","year":"2005","unstructured":"Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, et al. CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model. J Neurochem 2005, 93:310\u2013320.","journal-title":"J Neurochem"},{"key":"582_CR123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2014.11.004","volume":"74","author":"S Tyebji","year":"2015","unstructured":"Tyebji S, Saavedra A, Canas PM, Pliassova A, Delgado-Garc\u00eda JM, Alberch J, et al. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington\u2019s disease. Neurobiol Dis 2015, 74:41\u201357.","journal-title":"Neurobiol Dis"},{"key":"582_CR124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","volume":"28","author":"MR Domenici","year":"2007","unstructured":"Domenici MR, Scattoni ML, Martire A, Lastoria G, Potenza RL, Borioni A, et al. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice. Neurobiol Dis 2007, 28:197\u2013205.","journal-title":"Neurobiol Dis"},{"key":"582_CR125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","volume":"79","author":"W Li","year":"2015","unstructured":"Li W, Silva HB, Real J, Wang YM, Rial D, Li P, et al. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models. Neurobiol Dis, 2015, 79:70\u201380.","journal-title":"Neurobiol Dis"},{"key":"582_CR126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","volume":"1051","author":"R Sluyter","year":"2017","unstructured":"Sluyter R. The P2X7 receptor. Advances in experimental medicine and biology. 2017, 1051:17-53.","journal-title":"Advances in experimental medicine and biology."},{"key":"582_CR127","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.3103-16.2017","volume":"37","author":"P Illes","year":"2017","unstructured":"Illes P, Khan TM, Rubini P. Neuronal P2X7 receptors revisited: Do they really exist? J Neurosci 2017, 37:7049-62.","journal-title":"J Neurosci"},{"key":"582_CR128","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","volume":"37","author":"MT Miras-Portugal","year":"2017","unstructured":"Miras-Portugal MT, Sebasti\u00e1n-Serrano \u00c1, de Diego Garc\u00eda L, D\u00edaz-Hern\u00e1ndez M. Neuronal P2X7 receptor: Involvement in neuronal physiology and pathology. J Neurosci 2017, 37:7063-72.","journal-title":"J Neurosci"},{"key":"582_CR129","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1523\/JNEUROSCI.1469-04.2004","volume":"24","author":"JA Sim","year":"2004","unstructured":"Sim JA. Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci 2004, 24: 6307-6314.","journal-title":"J Neurosci"},{"key":"582_CR130","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.21-18-07143.2001","volume":"21","author":"SA Deuchars","year":"2001","unstructured":"Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 2001, 21:7143\u20137152.","journal-title":"J Neurosci"},{"key":"582_CR131","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","volume":"81","author":"B Sperl\u00e1gh","year":"2002","unstructured":"Sperl\u00e1gh B, K\u00f6falvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 2002, 81:1196-211.","journal-title":"J Neurochem"},{"key":"582_CR132","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2005.03465.x","volume":"95","author":"K Wirkner","year":"2005","unstructured":"Wirkner K, K\u00f6falvi A, Fischer W, G\u00fcnther A, Franke H, Gr\u00f6ger-Arndt H, et al. Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem 2005, 95:1421-37.","journal-title":"J Neurochem"},{"key":"582_CR133","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","volume":"14","author":"N Yue","year":"2017","unstructured":"Yue N, Huang H, Zhu X, Han Q, Wang Y, Li B, et al. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. J Neuroinflammation 2017, 14:102.\u00a0https:\/\/doi.org\/10.1186\/s12974-017-0865-y.","journal-title":"J Neuroinflammation"},{"key":"582_CR134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2007.11.064","volume":"1194","author":"Y Yu","year":"2008","unstructured":"Yu Y, Ugawa S, Ueda T, Ishida Y, Inoue K, Kyaw Nyunt A, et al. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res 2008, 1194:45\u201355.","journal-title":"Brain Res"},{"key":"582_CR135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","volume":"13","author":"MW Metzger","year":"2017","unstructured":"Metzger MW, Walser SM, Aprile-Garcia F, Dedic N, Chen A, Holsboer F, et al. Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice. Purinergic Signal 2017, 13:153\u2013170.","journal-title":"Purinergic Signal"},{"key":"582_CR136","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1476-5381.2011.01624.x","volume":"165","author":"M Masin","year":"2012","unstructured":"Masin M, Young C, Lim K, Barnes SJ, Xu XJ, Marschall V, et al. Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: Re-evaluation of P2X7 knockouts. Br J Pharmacol 2012,165: 978\u201393.","journal-title":"Br J Pharmacol"},{"key":"582_CR137","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.febslet.2005.05.073","volume":"17","author":"J S\u00e1nchez-Nogueiro","year":"2005","unstructured":"S\u00e1nchez-Nogueiro J, Mar\u00edn-Garc\u00eda P, Miras-Portugal MT. Characterization of a functional P2X7-like receptor in cerebellar granule neurons from P2X7 knockout mice. FEBS Lett 2005, 17:3783\u20133788.","journal-title":"FEBS Lett"},{"key":"582_CR138","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1523\/JNEUROSCI.1469-04.2004","volume":"24","author":"JA Sim","year":"2004","unstructured":"Sim JA, Young MT, Sung HY, North RA, Surprenant A. Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci 2004, 24:6307\u20136314.","journal-title":"J Neurosci"},{"key":"582_CR139","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","volume":"29","author":"CM Anderson","year":"2006","unstructured":"Anderson CM, Nedergaard M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci 2006, 29:257\u201362.","journal-title":"Trends Neurosci"},{"key":"582_CR140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-4159.2009.06179.x","volume":"110","author":"LMG Carrasquero","year":"2009","unstructured":"Carrasquero LMG, Delicado EG, Bustillo D, Guti\u00e9rrez-Mart\u00edn Y, Artalejo AR, Miras-Portugal MT. P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J Neurochem 2009, 110:879\u2013889.","journal-title":"J Neurochem"},{"key":"582_CR141","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1242\/jcs.034082","volume":"121","author":"M D\u00edaz-Hernandez","year":"2008","unstructured":"D\u00edaz-Hernandez M, Puerto A del, D\u00edaz-Hernandez JI, Diez-Zaera M, Lucas JJ, Garrido JJ, et al. Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons. J Cell Sci 2008, 121:3717\u201328.","journal-title":"J Cell Sci"},{"key":"582_CR142","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jnr.10676","volume":"73","author":"C Herv\u00e1s","year":"2003","unstructured":"Herv\u00e1s C, P\u00e9rez-Sen R, Miras-Portugal MT. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells. J Neurosci Res 2003, 73:384\u2013399.","journal-title":"J Neurosci Res"},{"key":"582_CR143","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12640-009-9020-6","volume":"15","author":"F Ortega","year":"2009","unstructured":"Ortega F, P\u00e9rez-Sen R, Delicado EG, Miras-Portugal MT. P2X7 Nucleotide Receptor is Coupled to GSK-3 Inhibition and Neuroprotection in Cerebellar Granule Neurons. Neurotox Res 2009, 15:193\u2013204.","journal-title":"Neurotox Res"},{"key":"582_CR144","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00210-014-1005-1","volume":"387","author":"P Rubini","year":"2014","unstructured":"Rubini P, Pagel G, Mehri S, Marquardt P, Riedel T, Illes P. Functional P2X7 receptors at cultured hippocampal astrocytes but not neurons. Naunyn Schmiedebergs Arch Pharmacol 2014, 387:943\u201354.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"582_CR145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainresbull.2018.07.016","volume":"151","author":"MT Khan","year":"2018","unstructured":"Khan MT, Deussing J, Tang Y, Illes P. Astrocytic rather than neuronal P2X7 receptors modulate the function of the tri-synaptic network in the rodent hippocampus. Brain Res Bull 2018, 151:164\u2013173.","journal-title":"Brain Res Bull"},{"key":"582_CR146","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","volume":"35","author":"B Sperl\u00e1gh","year":"2014","unstructured":"Sperl\u00e1gh B, Illes P. P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 2014, 35:537\u2013547.","journal-title":"Trends Pharmacol Sci"},{"key":"582_CR147","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","volume":"151","author":"E Adinolfi","year":"2018","unstructured":"Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F. The P2X7 receptor: A main player in inflammation. Biochem Pharmacol 2018, 151:234\u2013244.","journal-title":"Biochem Pharmacol"},{"key":"582_CR148","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1096\/fj.08-122275","volume":"23","author":"M D\u00edaz-Hern\u00e1ndez","year":"2009","unstructured":"D\u00edaz-Hern\u00e1ndez M, D\u00edez-Zaera M, S\u00e1nchez-Nogueiro J, G\u00f3mez-Villafuertes R, Canals JM, Alberch J, et al. Altered P2X7-receptor level and function in mouse models of Huntington\u2019s disease and therapeutic efficacy of antagonist administration. FASEB J 2009, 23:1893\u20131906.","journal-title":"FASEB J"},{"key":"582_CR149","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","volume":"117","author":"D Marcellino","year":"2010","unstructured":"Marcellino D, Su\u00e1rez-Boomgaard D, S\u00e1nchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S, et al. On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson\u2019s disease: studies with the P2X7 receptor antagonist A-438079. J Neural Transm 2010, 117:681\u2013687.","journal-title":"J Neural Transm"},{"key":"582_CR150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","volume":"81","author":"MRS Carmo","year":"2014","unstructured":"Carmo MRS, Menezes APF, Nunes ACL, Pli\u00e1ssova A, Rolo AP, Palmeira CM, et al. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology 2014, 81:142\u2013152.","journal-title":"Neuropharmacology"},{"key":"582_CR151","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3727\/096368917X695227","volume":"26","author":"EG Ferrazoli","year":"2017","unstructured":"Ferrazoli EG, de Souza HDN, Nascimento IC, Oliveira-Giacomelli \u00c1, Schwindt TT, Britto LR, et al. Brilliant blue-G but not fenofibrate treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson\u2019s disease. Cell Transplant 2017, 26:669\u2013677.","journal-title":"Cell Transplant"},{"key":"582_CR152","doi-asserted-by":"crossref","unstructured":"Oliveira-Giacomelli \u00c1, M. Albino C, de Souza HDN, Corr\u00eaa-Velloso J, de Jesus Santos AP, Baranova J, et al. P2Y6 and P2X7 receptor antagonism exerts neuroprotective\/ neuroregenerative effects in an animal model of Parkinson\u2019s disease. Front Cell Neurosci 2019, 13: 476\u201389.","DOI":"10.3389\/fncel.2019.00476"},{"key":"582_CR153","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","volume":"36","author":"T Jiang","year":"2015","unstructured":"Jiang T, Hoekstra J, Heng X, Kang W, Ding J, Liu J, et al. P2X7 receptor is critical in \u03b1-synuclein-mediated microglial NADPH oxidase activation. Neurobiol Aging 2015, 36:2304\u20132318.","journal-title":"Neurobiol Aging"},{"key":"582_CR154","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11302-017-9567-2","volume":"13","author":"A Wilkaniec","year":"2017","unstructured":"Wilkaniec A, G\u0105ssowska M, Czapski GA, Cie\u015blik M, Sulkowski G, Adamczyk A. P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells. Purinergic Signal 2017, 13:347\u2013361.","journal-title":"Purinergic Signal"},{"key":"582_CR155","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M010353200","volume":"276","author":"BJ Gu","year":"2001","unstructured":"Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 2001, 276:11135\u201311142.","journal-title":"J Biol Chem"},{"key":"582_CR156","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2013.04.049","volume":"546","author":"H Liu","year":"2013","unstructured":"Liu H, Han X, Li Y, Zou H, Xie A. Association of P2X7 receptor gene polymorphisms with sporadic Parkinson\u2019s disease in a Han Chinese population. Neurosci Lett 2013, 546:42\u201345.","journal-title":"Neurosci Lett"},{"key":"582_CR157","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","volume":"20","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S, Fredholm BB, Morelli M, Popoli P, Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997, 20:482\u2013487.","journal-title":"Trends Neurosci"},{"key":"582_CR158","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1523\/JNEUROSCI.22-20-09122.2002","volume":"22","author":"D Blum","year":"2002","unstructured":"Blum D, Gall D, Galas MC, D\u2019Alcantara P, Bantubungi K, Schiffmann SN. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. J Neurosci 2002, 22:9122\u20139133.","journal-title":"J Neurosci"},{"key":"582_CR159","first-page":"69","volume":"53","author":"B Zuchora","year":"2001","unstructured":"Zuchora B, Urba\u0144ska EM. Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid. Pol J Pharmacol 2001, 53:69\u201371.","journal-title":"Pol J Pharmacol"},{"key":"582_CR160","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","volume":"23","author":"PD Alfinito","year":"2003","unstructured":"Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci 2003, 23:10982\u201310987.","journal-title":"J Neurosci"},{"key":"582_CR161","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.neurobiolaging.2014.10.037","volume":"36","author":"M Gan","year":"2015","unstructured":"Gan M, Moussaud S, Jiang P, McLean PJ. Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. Neurobiol Aging 2015, 36:1209\u20131220.","journal-title":"Neurobiol Aging"},{"key":"582_CR162","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-019-0439-2","volume":"12","author":"JY Koh","year":"2019","unstructured":"Koh JY, Kim HN, Hwang JJ, Kim YH, Park SE. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: Possible therapeutic roles of cAMP and zinc. Mol Brain 2019, 12:18.\u00a0https:\/\/doi.org\/10.1186\/s13041-019-0439-2.","journal-title":"Mol Brain"},{"key":"582_CR163","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jnr.24119","volume":"96","author":"Y Qian","year":"2018","unstructured":"Qian Y, Xu S, Yang X, Xiao Q. Purinergic receptor P2Y6 contributes to 1-methyl-4-phenylpyridinium-induced oxidative stress and cell death in neuronal SH-SY5Y cells. J Neurosci Res 2018, 96:253\u2013264.","journal-title":"J Neurosci Res"},{"key":"582_CR164","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.4049\/jimmunol.1000212","volume":"186","author":"B Kim","year":"2011","unstructured":"Kim B, Jeong HK, Kim JH, Lee SY, Jou I, Joe EH. Uridine 5\u2019-Diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J Immunol 2011, 186:3701\u20133709.","journal-title":"J Immunol"},{"key":"582_CR165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12974-017-0795-8","volume":"14","author":"X Yang","year":"2017","unstructured":"Yang X, Lou Y, Liu G, Wang X, Qian Y, Ding J, et al. Microglia P2Y6 receptor is related to Parkinson\u2019s disease through neuroinflammatory process. J Neuroinflammation, 2017, 14:38.","journal-title":"J Neuroinflammation"},{"key":"582_CR166","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/glia.22693","volume":"62","author":"JJ Neher","year":"2014","unstructured":"Neher JJ, Neniskyte U, Hornik T, Brown GC. Inhibition of UDP\/P2Y 6purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo. Glia, 2014, 62:1463\u20131475.","journal-title":"Glia"},{"key":"582_CR167","doi-asserted-by":"crossref","unstructured":"Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res, 1992, 14:186\u2013195","DOI":"10.1016\/0169-328X(92)90173-9"},{"key":"582_CR168","doi-asserted-by":"crossref","unstructured":"Chen J-F. Adenosine receptor control of cognition in normal and disease. International Review of Neurobiology, vol. 119. Elsevier; 2014:257\u2013307.","DOI":"10.1016\/B978-0-12-801022-8.00012-X"},{"key":"582_CR169","doi-asserted-by":"crossref","unstructured":"Morelli M, Di Paolo T, Wardas J, Calon F, Xiao D, Schwarzschild MA. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPAinduced motor complications. Prog Neurobiol, 2007, 83:293\u2013309.","DOI":"10.1016\/j.pneurobio.2007.07.001"},{"key":"582_CR170","doi-asserted-by":"crossref","unstructured":"Haas HL, Selbach O. Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol, 2000, 362:375\u2013381.","DOI":"10.1007\/s002100000314"},{"key":"582_CR171","doi-asserted-by":"crossref","unstructured":"Hask\u00f3 G, Pacher P, Vizi ES, Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci, 2005, 26:511\u2013516.","DOI":"10.1016\/j.tips.2005.08.004"},{"key":"582_CR172","doi-asserted-by":"crossref","unstructured":"Othman T, Yan H, Rivkees SA. Oligodendrocytes Express Functional A1 Adenosine Receptors That Stimulate Cellular Migration. Glia, 2003, 44:166\u2013172.","DOI":"10.1002\/glia.10281"},{"key":"582_CR173","doi-asserted-by":"crossref","unstructured":"Burnstock G, Kennedy C. P2X Receptors in Health and Disease. Advances in Pharmacology, vol. 61. Academic Press Inc.; 2011:333\u2013372.","DOI":"10.1016\/B978-0-12-385526-8.00011-4"},{"key":"582_CR174","doi-asserted-by":"crossref","unstructured":"Khaira SK, Pouton CW, Haynes JM. P2X2, P2X4 and P2Y1 receptors elevate intracellular Ca 2+ in mouse embryonic stem cell-derived GABAergic neurons. Br J Pharmacol, 2009, 158:1922\u20131931.","DOI":"10.1111\/j.1476-5381.2009.00479.x"},{"key":"582_CR175","doi-asserted-by":"crossref","unstructured":"Burnstock G. Introduction: ATP and Its Metabolites as Potent Extracellular Agents. Curr Top Membr, 2003:1\u201327.","DOI":"10.1016\/S1063-5823(03)01001-9"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-020-00582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-020-00582-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-020-00582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:05:59Z","timestamp":1633565159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-020-00582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":175,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s12264-020-00582-8","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors claim that there are no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}